#United States #New York #Securities Fraud #Pomerantz LLP #Rezolute

Investor Alert: Pomerantz Law Firm Investigates Rezolute, Inc.

Pomerantz LLP, a distinguished law firm with a legacy of over 85 years in securities class actions, has initiated an investigation into claims made by investors of Rezolute, Inc. (NASDAQ: RZLT). This investigation comes in the wake of disturbing revelations regarding the company’s performance in a critical study involving its treatment for congenital hyperinsulinism.

On December 11, 2025, Rezolute released press information regarding their Phase 3 sunRIZE study, which was aimed at evaluating the efficacy of ersodetug. The results of this study were disappointing; Rezolute announced that the primary endpoint—measuring the average frequency of hypoglycemic events through self-monitored blood glucose—was not met. Although the highest dose of ersodetug showed a 45% reduction in these events, this was statistically insignificant compared to the placebo group and their 40% improvement. Moreover, the study also failed to meet one of its key secondary endpoints concerning average daily percent time in hypoglycemia, with the drug not performing as anticipated.

The stark outcomes of this research triggered a severe response in the market. Following the announcement, Rezolute's share price plummeted by $9.44, equivalent to a staggering 87.2% drop, settling at $1.77 on December 19, 2025. This dramatic decline raises questions about the transparency and accountability of the company’s management concerning their disclosures and business practices.

Investors who believe they may have been wronged are strongly encouraged to reach out to Pomerantz LLP. The firm is known for its commitment to fighting for the rights of investors and has a successful track record in recovering damages for class members in similar situations.

Founded by Abraham L. Pomerantz, who is often referred to as the father of the class action bar, the firm has become synonymous with corporate accountability, helping victims of securities fraud and other forms of corporate misconduct. With offices spanning from New York to Tel Aviv, Pomerantz is well-equipped to handle complex cases in the realm of securities law.

For investors seeking to join a potential class action or to gain more information regarding their rights, Wynne M. Moskow, a dedicated attorney at Pomerantz, can be contacted directly at [email protected] or by calling 646-581-9980, ext. 7980. Investors should act swiftly, ensuring they safeguard their investment rights.

As the landscape of investor protection continues to evolve, the ongoing investigation into Rezolute, Inc. underscores the importance of vigilance amongst investors. Familiarity with the signs of securities fraud and the resources available can empower investors, equipping them to make informed decisions in the face of corporate uncertainty.

With both ongoing investigations and market responses to corporate disclosures evolving, it will be crucial for investors to stay informed to navigate the complexities of today’s financial arena effectively.

Conclusion

The Pomerantz investigation represents not only a beacon of hope for affected investors of Rezolute, Inc. but also a reminder of the essential need for corporate transparency and investor vigilance in the fast-paced world of securities.